Windtree Therapeutics, Inc. (WINT) Reports Q4 Loss of $0.77
Tweet
Share
E-mailGet Alerts WINT Hot Sheet
Join SI Premium – FREE
Windtree Therapeutics, Inc. (NASDAQ: WINT) reported Q4 EPS of ($0.77), versus ($1.26) reported last year.
For earnings history and earnings-related data on Windtree Therapeutics, Inc. (WINT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Femasys Inc. (FEMY) Misses Q2 EPS by 20c
- Laser Photonics Corporation (LASE) Reports Q2 Loss of $0.08
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
